International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 3 (May-June 2026) Submit your research before last 3 days of June to publish your research paper in the issue of May-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 8 Issue 3
May-June 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Herb-drug Interactions in Polypharmacy or Ashwagandha in Stress and Cognitive Disorders

Author(s) Vinit Singh, Vikash Kumar, Nikhil Kumar Giri, Gautam Parmar, Harshit Kumar
Country India
Abstract Abstract
Polypharmacy among older adults increases the risk of herb–drug interactions, particularly in regions such as the Caribbean where herbal medicine use is prevalent. Withania somnifera (Ashwagandha), an adaptogenic herb from Ayurvedic medicine, is increasingly used for managing stress, anxiety, depression, insomnia, and age-related cognitive decline. Its mechanisms involve modulation of the hypothalamic–pituitary–adrenal (HPA) axis, sympathetic–adrenal–medullary (SAM) activity, and GABAergic and serotonergic pathways. Despite reported therapeutic benefits, Ashwagandha’s diverse bioactive compounds and variability in preparations complicate the prediction of pharmacokinetic and pharmacodynamic interactions with conventional drugs. In multimorbid, polymedicated patients, such interactions may result in altered drug metabolism, additive pharmacological effects, or therapeutic failure. This review highlights the urgent need for drug reconciliation systems, pharmacovigilance, and well-designed clinical trials to evaluate Ashwagandha’s safety profile within polypharmacy settings. Greater awareness and evidence-based guidance are essential for healthcare professionals to optimize outcomes while minimizing risks in integrative medicine approaches.
Keywords Ashwagandha, Withania somnifera, polypharmacy, herb–drug interactions, cognitive disorders, stress, pharmacokinetics, pharmacodynamics, adaptogen, Caribbean, pharmacovigilance.
Field Medical / Pharmacy
Published In Volume 7, Issue 4, July-August 2025
Published On 2025-08-17
DOI https://doi.org/10.36948/ijfmr.2025.v07i04.53901
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 2Cover Page Vol 8 Isu 1Cover Page Vol 7 Isu 6

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com
Powered by Sky Research Publication and Journals